But stocks could be in for some surprises. Shares have increased by 130% in one month. In 2022, MARA's EPS is forecast to hit $4.75 (min: $4.75, max: $4.75). to determine if its dividend payments are covered by earnings. DOC is forecast to become profitable over the next 3 years, which is considered above average market growth. CloudMD Closes Acquisition of Rxi, Providing an Established Specialty Drug Management and Patient Support Program to the Employer Market. It offers CloudMD telemedicine application, a telemed... Show more. Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings. Dogecoin outlook for 5 years. Taylor believes that gross margin is in-line with CloudMD’s of 30% and says that if the earnout were trigged by VisionPro growing 50% annually across 2021 and 2022, it would make Canaccord upgrade their forecast. DOC is unprofitable, so we can't compare its. 60-Month Beta: Coefficient that measures the volatility of a stock's returns relative to the market (S&P 500). It is based on a 60-month historical regression of the return on the stock onto the return on the S&P 500. All currency forecasts. ( 1.3 years average tenure), which suggests a new team. DOC is unprofitable, and losses have increased over the past 5 years at a rate of 53.8% per year. After a bullish start, here's the stock market outlook for Biden's next 100 days Published Thu, Apr 29 2021 6:36 AM EDT Updated Thu, Apr 29 2021 9:15 AM EDT Bob Pisani @BobPisani Unable to evaluate DOC's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts. The CAD to USD forecast at the end of the month 0.952, change for April 1.2%. TSLA stock can potentially earn more with long-dated deep-in-the-money options. (-11.46%), as it is currently unprofitable. Pessimistic forecast: 5.23. Plug Power stock price stood at $22.24. Nikola price started in 2021 at $10.05. Unable to compare DOC's earnings growth over the past year to its 5-year average as it is currently unprofitable. Explore strong dividend paying companies in the Healthcare industry. In the beginning rate at 0.952 US Dollars. DOC is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare industry (34.1%). Their average twelve-month price target is C$3.88, predicting that the stock has a possible upside of 96.70%. Reducing Debt: DOC had negative shareholder equity 5 years ago, but is now positive and has therefore improved. More Details, Trading at 39% below our estimate of its fair value, Earnings are forecast to grow 113.8% per year, Shareholders have been substantially diluted in the past year, Significant insider selling over the past 3 months. is forecast to be low in 3 years time (4%). Analysts expect this to improve further in 2022, with an average revenue forecast of $151.37 Billion. Accelerating Growth: Unable to compare DOC's earnings growth over the past year to its 5-year average as it is currently unprofitable. PE vs Industry: DOC is unprofitable, so we can't compare its PE Ratio to the Canadian Healthcare industry average. How is CloudMD Software & Services forecast to perform in the next 1 to 3 years based on estimates from 5 analysts? Estimated Average Forecasted Nokia Price: 5.51. Shares Outstanding (b/fd) 199,364,698 / 222,426,761. View real-time stock prices and stock quotes for a full financial overview. Stable Dividend: Insufficient data to determine if DOC's dividends per share have been stable in the past. $3.43 – $0.54 CAD. Estimated Average Forecasted Ideanomics Price: 2.71 Positive intraday dynamics of the instrument is expected with 3.433% volatility is expected. The forecasts show improvement YOY from 2020, which was a difficult year of business due to COVID disrupting the demand and supply of Ford vehicles. According to the latest long-term forecast, Plug Power price will hit $30 by the end of 2022 and then $40 by the end of 2024. Negative monthly dynamics of the instrument is expected with 7.277% volatility is expected.. Pessimistic forecast: 44.40 Optimistic: 47.88 Pfizer stock forecast for Feb 2022. High Growth Earnings: DOC's is expected to become profitable in the next 3 years. View CloudMD Software & Services' (CVE:DOC) earnings history, next earnings date and earnings forecasts from top-rated Wall Street analysts at MarketBeat. Growing Dividend: Insufficient data to determine if DOC's dividend payments have been increasing. Below Fair Value: DOC (CA$1.85) is trading below our estimate of fair value (CA$3.03). Their … On average, analysts forecast that BABA's EPS will be $8.65 for 2022, with the lowest EPS forecast at $7.70, and the highest EPS forecast at $9.69. in the past year, with total shares outstanding growing by 120.7%. We surveyed a group of over 300 investors on whether shares of Nio Inc (NYSE:NIO) will reach $100 by 2022. All cryptocurrency predictions . 2 Wall Street analysts have issued ratings and price targets for CloudMD Software & Services in the last 12 months. ). Name Symbol Last Close … Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. But this year the company is expecting that doctor growth to be much much higher—with a new full time sales team and the coronavirus pandemic. It offers CloudMD telemedicine application, a telemed, Unless specified all financial data is based on a yearly period but updated quarterly. Options (avg. Forecast Spread: 6,77: 15,0 14,7 2,4%: 91,1: Operating income (EBITDA) M CAD: Released Forecast Spread-11,3-4,80-136%: 1,80: Operating profit (EBIT) M CAD: Released Forecast Spread-12,7-7,01-81%-2,29: Pre-Tax Profit (EBT) M CAD: Released Forecast Spread-13,8-7,32-89%-2,52: Net income M CAD: Released Forecast Spread-4,72-12,3-9,26-33%-4,50: EPS CAD: Released Forecast Spread-0,07-0,11-0,08 … QQQ 340.15 (-0.43%) AAPL 134.39 (-0.24%) MSFT 261.97 (+0.16%) FB … DOC (CA$1.85) is trading below our estimate of. Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. /* sc-component-id: apccz2-0 */ Canadian Dollar to US Dollar forecast for April 2022. Canadian Dollar to US Dollar forecast for April 2022. 2 equities research analysts have issued twelve-month target prices for CloudMD Software & Services' stock. High Dividend: Unable to evaluate DOC's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts. The average for the month 0.950. Estimated Average Forecasted Ideanomics Price: 2.71 Positive intraday dynamics of the instrument is expected with 3.433% volatility is expected. This price target is based on 2 analysts offering 12 month price targets for CloudMD Software & Services in the last 3 months. Please note that any opinions, estimates or forecasts regarding CloudMD’s performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of the Company. High ROE: DOC has a negative Return on Equity (-11.46%), as it is currently unprofitable. On average, analysts forecast that TXMD's EPS will be $-0.18 for 2022, with the lowest EPS forecast at $-0.25, and the highest EPS forecast at $-0.09. CloudMD stock has soared more than 200% since its debut at TSXV in June of this year. DOC exceeded the Canadian Healthcare industry which returned 35.2% over the past year. High Growth Revenue: DOC's revenue (32.6% per year) is forecast to grow faster than 20% per year. On average, analysts forecast that TXMD's EPS will be $-0.42 for 2021, with the lowest EPS forecast at $-0.50, and the highest EPS forecast at $-0.37. In this episode, I sit down and chat with CloudMD CEO Dr. Essam Hamza as we discuss everything CloudMD. Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 120.7%. for more than 3 years based on its current, Insufficient data to determine if DOC has enough. VANCOUVER, British Columbia, Sept. 29, 2020 (GLOBE NEWSWIRE) -- CloudMD Software & Services Inc. (TSXV: DOC, OTCQB: DOCRF, Frankfurt: 6PH) (the “Company” or “CloudMD”), announces the granting of stock options to purchase an aggregate of 525,000 common shares of the Company at an exercise price of $2.15 per share for a five year term. CloudMD Software & Services Inc Stock Price Forecast, "DOC" Predictons for2026 Forecast Cash Runway: Insufficient data to determine if DOC has enough cash runway if its free cash flow continues to grow or shrink based on historical rates. In the beginning rate at 0.941 US Dollars. Experienced Board: DOC's board of directors are not considered experienced ( 0.8 years average tenure), which suggests a new board. Insider Buying: DOC insiders have sold more shares than they have bought in the past 3 months. ( 0.8 years average tenure), which suggests a new board. 05/03/2021. Long Term Liabilities: DOC's short term assets (CA$63.4M) exceed its long term liabilities (CA$6.7M). CloudMD is covered by the analysts listed below. Return vs Industry: DOC exceeded the Canadian Healthcare industry which returned 35.2% over the past year. Dr. Essam Hamza, MD has been Chief Executive Officer and Director of CloudMD Software & Services Inc. (formerly known as Premier Health Group Inc.) since August 31, 2018 and August 2, 2018 respectively. The acquisition is subject to customary closing conditions, including the execution of a definitive acquisition agreement and receipt of TSX Venture exchange approval. The Company has developed proprietary technology to deliver quality healthcare through the combination of connected primary care clinics, telemedicine, and artificial intelligence (AI). CloudMD Closes Acquisition of Rxi, Providing an Established Specialty Drug Management and Patient Support Program to the Employer Market, CloudMD Reports Record Fourth Quarter 2020 Revenue; On Track for Significant Growth in 2021, Interim 2021 Earnings Release (Projected), Bloom Burton & Co. Healthcare Investor Conference, Laurentian Bank Securities Institutional Investor Conference - Panel, Acquisition of Oncidium Inc by CloudMD Software & Services Inc Call. Positive monthly dynamics of the instrument is expected with 9.616% volatility is expected. Their forecasts range from $3.25 to $3.50. Historical Forecasts. (NASDAQ: MARA) Marathon Digital Holdings's current Earnings Per Share (EPS) is $0.84. Stable Cash Runway: DOC has sufficient cash runway for more than 3 years based on its current free cash flow. Estimated Average Forecasted Pfizer Price: 45.54. DOC exceeded the Canadian Market which returned 37.5% over the past year. This suggests a possible upside of 94.7% from the stock's current price. All rights reserved. What Does CloudMD Software & Services Inc.'s (CVE:DOC) Share Price Indicate? For NIO Limited stock forecast 2022, 12 predictions are offered for each month of 2022 with average NIO Limited stock forecast of $24.33, a high forecast of $28.73, and a low forecast of $18.85. CloudMD Presentation_April Updated This more-cyclical era won’t begin until 2022 or 2023, but it’s coming. This forecast should be taken as a general direction, not a finely-tuned prediction. DOC had negative shareholder equity 5 years ago, but is now positive and has therefore improved. The current price/book ratio (P/B) is 10.28. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. How is CloudMD Software & Services's financial position? View CloudMD Software & Services' (CVE:DOC) earnings history, next earnings date and earnings forecasts from top-rated Wall Street analysts at MarketBeat. 05/12/2021. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. 2021 bearish dynamics of the Apple Stocks is expected with an optimal forecast of 126.26 and a daily volatility of 0.624%.. Pessimistic forecast: 125.91 Optimistic: 126.70 VANCOUVER, British Columbia, Oct. 02, 2020 (GLOBE NEWSWIRE) -- CloudMD Software & Services Inc. (TSXV: DOC, OTCQB: DOCRF, Frankfurt: 6PH) (the “Company” or “CloudMD… Additionally, subject to the achievement of certain performance conditions in 2021 and 2022, Snapclarity may earn an additional $3.65M in equity-based consideration. The current price/book ratio (P/B) is 10.28. CloudMD Software & Services Inc.'s company bio, employee growth, exchange listings and data sources, CloudMD Software & Services Inc., a healthcare technology company, provides SaaS based health technology solutions to medical clinics in North America. No need to calculate the sustainability of DOC's dividend in 3 years as they are not forecast to pay a notable one for the Canadian market. CloudMD Software & Services Inc., a healthcare technology company, provides SaaS based health technology solutions to medical clinics in North America. Experienced Management: DOC's management team is not considered experienced ( 1.3 years average tenure), which suggests a new team. Nokia stock forecast for Dec 2022. For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway. CloudMD stock is currently trading at a price-to-sales ratio of 31.2. If Covid defined the 2020 stock market, lingering effects of the virus frame the stock market forecast for 2021. CloudMD has been growing its recurring SAAS (Software-as-a-Service) revenue by 30% YoY with its EMR system. Optimistic: 5.94. Revenue vs Market: DOC's revenue (32.6% per year) is forecast to grow faster than the Canadian market (5.6% per year). DOC is unprofitable, so we can't compare its. How volatile is CloudMD Software & Services's share price compared to the market and industry in the last 5 years? This suggests a possible upside of 112.3% from the stock's current price. Year High – Low. Their average twelve-month Google price target is $2,069.48, predicting that the stock has a possible downside of 1.32%. How experienced are the management team and are they aligned to shareholders interests? VANCOUVER, British Columbia, Sept. 29, 2020 (GLOBE NEWSWIRE) -- CloudMD Software & Services Inc. (TSXV: DOC, OTCQB: DOCRF, Frankfurt: 6PH) (the “Company” or “CloudMD”), announces the granting of stock options to purchase an aggregate of 525,000 common shares of the Company at an exercise price of $2.15 per share for a five year term. High exchange rate 0.967, low 0.938. He. Share your opinion and gain insight from other stock traders and investors. Market Capitalization. Other Technology sector assets. DOC is trading below fair value by more than 20%. On average, analysts forecast that MARA's EPS will be $2.10 for 2021, with the lowest EPS forecast at $2.10, and the highest EPS forecast at $2.10. It is based on a 60-month historical regression of the return on the stock onto the return on the S&P 500. I purchased these shares on 8/31/2020 and CloudMD +55.75% and … CloudMD Presentation_April Updated Investor Presentation. Essam's compensation has increased whilst the company is unprofitable. He... Show more. price/expiration) $0.75 / 3.78 years. CloudMD stock halt request of company, more big news???!!!! Summary on Lordstown’s Forecast for 2022. CloudMD … All stock predictions. Nikola Stock Price Forecast 2021-2022. CloudMD Software & Services, Inc. Stock Price Forecast for 2022: January 2022: Open: 0.000001: Close: 0.000001: Min: 0.000001: Max: 0.000001: Change: -559866.77 % CloudMD Software & Services, Inc. Stock Price Forecast for 2022: February 2022: Open: 0.000001: Close: 0.000001: Min: 0.000001: Max: 0.000001: Change: -236135.81 % A high-level overview of CloudMD Software & Services Inc. (DOCRF) stock. CloudMD stock (DOC) (DOCRF), CloudMD CEO interview! Insufficient data to determine if DOC's dividend payments have been increasing. Dr. Essam Hamza, MD has been Chief Executive Officer and Director of CloudMD Software & Services Inc. (formerly known as Premier Health Group Inc.) since August 31, 2018 and August 2, 2018 respectively. Price/Sales: Latest closing price divided by the last 12 months of revenue/sales per share. In conclusion, Lordstown Motors has exciting prospects moving into the second half of 2021. The stock options were granted pursuant to the Company’s Stock … Volatility Over Time: DOC's weekly volatility (8%) has been stable over the past year. Pfizer stock forecast for Apr 2022. Stable Share Price: DOC is not significantly more volatile than the rest of Canadian stocks over the past 3 months, typically moving +/- 8% a week. What is CloudMD Software & Services's current dividend yield, its reliability and sustainability? Pfizer stock forecast for Mar 2022. The year that brought so many surprises is shaping up to be a surprisingly good one for investors, and that’s a timely reminder for 2021. On 18 May. Analyzing CloudMD Software & Services (OTCMKTS:DOCRF) stock? Well Health was well ahead of CloudMD and in the last week CloudMD has moved ahead of Well Health. (2.9x) compared to the CA Healthcare industry average (4x). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. Shares have increased by 130% in one month. Future ROE: DOC's Return on Equity is forecast to be low in 3 years time (4%). DOC's short term assets (CA$63.4M) exceed its. - Analysts Consensus: $90.4MM Revenue for 2021 (2022: $144.5MM) - Analysts Consensus: $3.1MM EBITDA Profit for 2021 (2022: $11.7MM) - Analysts Consensus 2021 Target Price: $4.18/share. Price trends tend to persist, so it's worth looking at them when it comes to a share like CloudMD Software & Services Inc. Over the past six months, the relative strength of its shares against the market has been 0.231k%. 60-Month Beta: Coefficient that measures the volatility of a stock's returns relative to the market (S&P 500). Pessimistic forecast: 47.58. Is There An Opportunity With CloudMD Software & Services Inc.'s (CVE:DOC) 48% Undervaluation? Buy LEAPS to gain from Tesla’s 50% rise by 2022. Is CloudMD Software & Services undervalued compared to its fair value and its price relative to the market? Who are the major shareholders and have insiders been buying or selling? Buy LEAPS to take advantage of Tesla’s expected rise by 2022. In the beginning rate at 0.952 US Dollars. How has CloudMD Software & Services performed over the past 5 years? This page has economic forecasts for the United States including a long-term outlook for the next decades, plus medium-term expectations for the next four quarters and short-term market predictions for the next release affecting the the United States economy. --CloudMD Software& Services Inc., a telehealth company revolutionizing the delivery of healthcare to patients, announced its financial results for the second quarter ending June 30, 2020. CAD to USD forecast for May 2022. Growing Profit Margin: DOC is currently unprofitable. Quality Earnings: DOC is currently unprofitable. SaaS revenue is highly lucrative! continues to grow or shrink based on historical rates. The rise from today to year-end: +16%. .cMdFqC{height:525px;} @media (max-width:767px){.cMdFqC{height:459px;}} @media (max-width:1023px){}.UupjJ{height:358px;} @media (max-width:767px){.UupjJ{height:654px;}} @media (max-width:1023px){.UupjJ{height:355px;}}.kfFGpR{height:561px;} @media (max-width:767px){.kfFGpR{height:491px;}} @media (max-width:1023px){}.kIurKX{height:335px;} @media (max-width:767px){} @media (max-width:1023px){.kIurKX{height:327px;}}@media (max-width:767px){} @media (max-width:1023px){}.hpDZqm{height:543px;} @media (max-width:767px){.hpDZqm{height:475px;}} @media (max-width:1023px){} The story with this stock is very simple. Pfizer stock forecast for Jan 2022. This page has economic forecasts for Country List including a long-term outlook for the next decades, plus medium-term expectations for the next four quarters and short-term market predictions for the next release affecting the Country List economy. have sold more shares than they have bought in the past 3 months. VANCOUVER, British Columbia, Sept. 29, 2020 (GLOBE NEWSWIRE) -- CloudMD Software & Services Inc. (TSXV: DOC, OTCQB: DOCRF, Frankfurt: 6PH) (the “Company” or “CloudMD… DOC's is expected to become profitable in the next 3 years. Debt Level: DOC's debt to equity ratio (2.5%) is considered satisfactory. DOCRF | Complete CloudMD Software & Services Inc. stock news by MarketWatch. Estimated Average Forecasted Pfizer Price: 49.78. I see CloudMD as the best way to do that in the junior sector (where the leverage is! Maximum, minimum and averaged prices of Dogecoin. Ideanomics stock forecast for 14.05.2021. Optimistic: 52.64. Learn more here. View DOCRF's stock price, price target, earnings, forecast, insider trades, and news at MarketBeat. On average, they expect CloudMD Software & Services' stock price to reach C$3.88 in the next twelve months. Today, Nikola traded at $11.57, so the price increased by 15% from the beginning of the year. Their forecasts range from C$3.50 to C$4.25. The average price target is $3.38, with a high forecast of $3.50 and a low forecast of $3.25. ($USD199.19K) is below average for companies of similar size in the Canadian market ($USD792.56K). to the Canadian Healthcare industry average. CloudMD is literally the Canadian version of Teladoc Health—just at an earlier stage in the growth curve. If the company can stick to their delivery forecasts without delays there is no doubt the revenue surge will see strong investor backing. Compensation vs Earnings: Essam's compensation has increased whilst the company is unprofitable. In the near-term, the … CloudMD Reports Record Fourth Quarter 2020 Revenue; On Track for Significant Growth in 2021 April 28, 2021 CloudMD to Acquire Oncidium, One of the Largest … The market desperately wants to own teleHealth right now (see also the stock charts of LVGO-NASD and CATS-NASD). This page has economic forecasts for Country List including a long-term outlook for the next decades, plus medium-term expectations for the next four quarters and short-term market predictions for the next release affecting the Country List economy. At the beginning of April 2021, 24 Wall Street analysts, including The Goldman Sachs Group, Bloomberg, Credit Suisse, Morgan Stanley, and the USB Group, have issued ratings and price targets for Boeing this year. The average price target represents a 103.31% upside from the last price of $1.66. High exchange rate 0.967, low 0.938. Earnings vs Savings Rate: DOC is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (1.5%). .crwFFe{-webkit-box-flex:1;-webkit-flex-grow:1;-ms-flex-positive:1;flex-grow:1;-webkit-flex-basis:0;-ms-flex-preferred-size:0;flex-basis:0;position:relative;width:100%;min-height:0px;max-width:100%;-webkit-flex:0 0 100%;-ms-flex:0 0 100%;flex:0 0 100%;max-width:100%;} @media (max-width:575px){} @media (min-width:576px){} @media (max-width:767px){} @media (min-width:768px){} @media (max-width:1023px){} @media (min-width:1024px){.crwFFe{-webkit-flex:0 0 100%;-ms-flex:0 0 100%;flex:0 0 100%;max-width:100%;}} @media (max-width:1199px){} @media (min-width:1200px){}.dkFrRn{-webkit-box-flex:1;-webkit-flex-grow:1;-ms-flex-positive:1;flex-grow:1;-webkit-flex-basis:0;-ms-flex-preferred-size:0;flex-basis:0;position:relative;width:100%;min-height:0px;max-width:100%;-webkit-flex:0 0 100%;-ms-flex:0 0 100%;flex:0 0 100%;max-width:100%;} @media (max-width:575px){} @media (min-width:576px){} @media (max-width:767px){} @media (min-width:768px){} @media (max-width:1023px){} @media (min-width:1024px){.dkFrRn{-webkit-flex:0 0 50%;-ms-flex:0 0 50%;flex:0 0 50%;max-width:50%;}} @media (max-width:1199px){} @media (min-width:1200px){} /* sc-component-id: sc-5uk97a-0 */ Dogecoin price prediction for each month in 2021, 2022, 2023 and 2024. The CAD to USD forecast at the end of the month 0.952, change for April 1.2%. Google Stock Price Forecast for 2021 - Expert Predictions 42 Wall Street analysts have issued ratings and price targets for Alphabet in the last 12 months. The average NIO Limited stock forecast 2022 represents a -27.78% decrease from the last price of $33.68. Increases CloudMD’s annualized revenue run rate to over $120 million with positive Adjusted EBITDAOncidium is one of Canada’s leading health management companies with a … Learn more, CloudMD Software & Services Inc.'s (CVE:DOC) Profit Outlook. Earnings vs Market: DOC is forecast to become profitable over the next 3 years, which is considered above average market growth. Xebec Adsorption Inc Stock Price Forecast for 2022: January 2022: Open: 12.107: Close: 12.414: Min: 12.107: Max: 12.457: Change: 2.47 % Xebec Adsorption Inc Stock Price Forecast for 2022: February 2022: Open: 12.411: Close: 12.338: Min: 12.286: Max: 12.411: Change: -0.59 % Xebec Adsorption Inc Stock Price Forecast for 2022: March 2022: Open: 12.349: Close: 12.429 Unable to evaluate DOC's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts. 337927). Estimated Average Forecasted Pfizer Price: 50.94. $410 Million CAD. CAD to USD forecast for May 2022. Compensation vs Market: Essam's total compensation ($USD199.19K) is below average for companies of similar size in the Canadian market ($USD792.56K). CloudMD is part of CloudMD Software & Services Inc.. Ideanomics stock forecast for 14.05.2021. Nio Stock Forecast. CloudMD Software & Services Inc., a healthcare technology company, provides SaaS based health technology solutions to medical clinics in North America. Dogecoin to dollar (DOGE to USD) converter. Copyright © 2021 Surperformance. Cloudmd Software & Services Inc stocks price quote with latest real-time prices, charts, financials, latest news, technical analysis and opinions. CloudMD Software & Services offers SAAS based health technology solutions to medical clinics across Canada. Positive monthly dynamics of the instrument is expected with 11.911% volatility is expected. On average, analysts forecast that BABA's EPS will be $10.49 for 2023, with the lowest EPS forecast at $8.85, and the highest EPS forecast at $12.04. CloudMD stock has soared more than 200% since its debut at TSXV in June of this year. DOC is forecast to become profitable over the next 3 years, which is considered faster growth than the. than the rest of Canadian stocks over the past 3 months. In the beginning rate at 0.941 US Dollars. Excellent balance sheet with high growth potential.